Skip to content

Clinical trials

Liver Neoplasms trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Phase: Not applicable Clear all

292 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20033
20041
20053
20063
20077
20087
20099
20107
20113
201211
201310
201414
20159
201615
201716
201817
201918
202017
202117
202220
202324
202421
202515
202621

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed112
Unknown status68
Recruiting43
Terminated20
Not yet recruiting17
Active, not recruiting16
Withdrawn12
Enrolling by invitation3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital9
Massachusetts General Hospital5
RenJi Hospital5
Washington University School of Medicine5
Assistance Publique - Hôpitaux de Paris4
National Cheng-Kung University Hospital4
Sun Yat-sen University4
The University of Hong Kong4
Tianjin Third Central Hospital4
Wake Forest University Health Sciences4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms292
Carcinoma, Hepatocellular91
Pancreatic Neoplasms45
Stomach Neoplasms33
Colorectal Neoplasms28
Esophageal Neoplasms27
Lung Neoplasms26
Neoplasms25
Breast Neoplasms24
Colonic Neoplasms23

Trials

Showing 26 to 50 of 292. Each trial links to its page on Pharma Observatory.

192 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.